DCPS介导的SLC4A7剪切作用维持的溶酶体稳态,使胶质母细胞瘤干细胞产生依赖性
Lysosomal homeostasis maintained by DCPS-mediated SLC4A7 splicing confers dependency in glioblastoma stem cells
Guan Yian, Lv Shihui, Tang Junwei, Zou Kefeng, Li Xinyu, Zhang Shengnan, Liu Hailun, Gao Xue, Zhu Zhe, Rich Jeremy N., Qiu Zhixin
Journal:Cell Death & Disease
IF:12.2
DOI:10.1038/s41419-026-09255-2
PMID:
Published:2026-09-08
research field:肿瘤学分子生物学细胞生物学RNA生物学表观遗传学神经肿瘤学肿瘤干细胞
Abstract
Glioblastoma (GBM) is an aggressive brain tumor driven by GBM stem cells (GSCs), which lack therapeutic targets. Here, we identify RNA decapping enzyme DCPS as an essential regulator of GSC maintenance and GBM progression. Epigenetically regulated DCPS expression levels correlate with GBM stemness and poor patient survival. Targeting DCPS impairs GSC stemness and extends survival of GBM-bearing mouse models. Mechanistically, DCPS controls the alternative splicing landscape of GSCs independently of its decapping enzyme activity. DCPS ensures mRNA stability of SLC4A7 by suppressing exon skipping and nonsense-mediated decay. Inhibition of the DCPS-SLC4A7 axis leads to intracellular acidification, lysosomal membrane permeabilization, and subsequent pyroptosis. SLC4A7 is overexpressed in GBM patients and is essential for GSC stemness. Collectively, our findings uncover a DCPS-SLC4A7 axis that maintains GBM stemness and malignancy, linking epigenetic regulation, RNA biology, and lysosomal homeostasis and highlighting a promising therapeutic vulnerability in GBM.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


